UNH

Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates here.

San Juan Regional Medical Center has strengthened its clinical operations with several new Oracle Health solutions that help streamline patient flow, improve bed management, and enhance operational visibility. The new capabilities give clinical and operational teams a shared, up-to-date view of capacity and demand, helping them coordinate care efficiently, limit delays, and support a predictable patient experience. Oracle Health and Optum supported the implementation, combining connected clinica

UnitedHealth Group’s recovery is gaining traction, with improving MCR, two 2026 EPS guidance raises, and stronger cash flow. Read more on UNH stock here.

CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.

eHealth says surging 2027 health costs are pushing smaller employers toward ICHRAs, potentially expanding individual coverage demand.

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

Based on the average brokerage recommendation (ABR), UnitedHealth (UNH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.

CNBC Final Trades: Simpson picks UnitedHealth, Ethridge selects Goldman Sachs, and Terranova favors Teradyne after strong earnings.

Schwab US Dividend Equity ETF (SCHD) has outperformed SPY year-to-date, widening its lead during recent market volatility.